The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.
本发明属于EP1受体
配体领域,更具体地,它指的是具有EP1受体亲和力和选择性的一般式(I)化合物。该发明还涉及它们的制备过程,它们作为治疗和/或预防由EP1受体介导的疾病或疾病的药物的使用,以及包含它们的制药组合物。